BioClinica, Inc. Reports 15.7% Growth in Service Revenue and 26.1% Increase in Non-GAAP Operating Income for Third Quarter

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced its financial results for the third quarter and nine months ended September 30, 2012. Financial highlights for the quarter ended September 30, 2012 include: Service revenues increased 15.7% to a record $19.2 million as compared with $16.6 million for the same period 2011.